Chilean Biotech PhageLab joins panel at the Animal AgTech Innovation Summit 2025
Company discusses opportunities and challenges in fighting Salmonella and advancing innovation in Brazilian agribusinessPhageLab, a leading biotech company specializing in sustainable solutions to control bacterial outbreaks such as Salmonella and E. coli in livestock, will take part in the Animal AgTech Innovation Summit 2025, held in Dallas (USA). The company will be represented by its CFO, Sabrina Torgan, in the panel “Latin American Breakfast: North America and Latin America Collaboration,” on April 9, at 9 AM, on the event's main stage.
The summit gathers business leaders, investors, and experts from across the Americas to discuss how countries are addressing challenges related to climate resilience and sustainability, while exploring opportunities for collaboration. PhageLab’s participation highlights the growing importance of Brazil and Latin America as epicenters of technological innovation in animal production, and reinforces the need for market integration and the adoption of personalized, effective, and sustainable solutions.
“We believe the future of agribusiness lies in integrated solutions based on data science and tailored to the microbiological realities of each region. Brazil is one of the world’s largest and most complex production hubs in terms of bacterial diversity. That’s why investing in technology, applied research, and global collaboration is essential to ensure food security and sustainable productivity gains,” says Sabrina Torgan, CFO of PhageLab.
Applied Innovation: AI, Machine Learning, and Bacteriophages Against Salmonella
PhageLab is one of the world’s pioneers in using bacteriophages combined with Artificial Intelligence and Machine Learning to develop precision treatments for multidrug-resistant bacteria, with a special focus on controlling Salmonella in poultry farming. In 2024, the company launched INSPEKTOR® in Brazil—a solution tailored to local microbiological characteristics, with proven effectiveness in reducing bacterial loads by up to 6 logs, according to a study published in the scientific journal Poultry Science.
Now, the company is introducing two new versions: INSPEKTOR® BC, with higher concentration, and INSPEKTOR® D, adapted to the specific microbiological landscape of Brazilian farms.
Beyond its product technology, PhageLab stands out for its technical support. Each producer is assisted by a dedicated team of veterinarians and agricultural technicians who oversee the application of phages in the field—from the product's arrival at the farm to post-treatment monitoring.
With a focus on customization, speed, and efficacy, PhageLab delivers a complete diagnostic-to-treatment cycle in up to 30 days—and is already working to shorten this window to 24 hours by 2026, positioning itself as one of the most advanced healthtechs in the agribusiness sector.
Brazil as a Global Model
PhageLab’s Brazilian operations are a benchmark due to their combination of large-scale production, microbiological complexity, and strong demand for antibiotic-free solutions. Major poultry producers are already using PhageLab’s products, supported by local technical teams who ensure the application process is optimized for maximum effectiveness.
Global Recognition
In 2024, PhageLab was recognized by the World Economic Forum as one of the Top 100 most promising startups in the world, standing out for its ability to scale scientific solutions with direct impact on food security, environmental sustainability, and the reduction of antibiotic use in the food production chain.
The company’s presence at the Animal AgTech Innovation Summit 2025 underscores its commitment to open innovation, global knowledge exchange, and building a more efficient, transparent, and resilient production chain